The Brexit effect: What is happening to the UK science industry?
It’s still impossible to know the full effect of the Brexit referendum on the UK science industry. The vote to leave the European Union...
Manisha Raja, Dermatology Account Manager at LEO Pharma and winner of the Secondary Care...
Congratulations on your Pf Award win Manisha, how did it feel when your name was announced? Thank you! My jaw dropped when my name was...
BD and iTS Leadership demonstrate how honesty and an appetite to solve problems can...
Tracey Clarke
HR Director for UK/Ireland and the Nordic region, BD, on how to create a no-blame culture of continuous learning. What is BD? BD is a...
Amryt Pharma and University College Dublin unite to bring hope to ‘butterfly children’, who...
Novel gene therapy shows promise Amryt Pharma and University College Dublin unite to bring hope to ‘butterfly children’, who suffer from an incurable skin...
Consilient Health’s Ian Sampson on the importance of traditional sales skills in an evolving...
More than ever, we are adopting new and innovative ways to communicate, and pharma is no different. Whilst traditional sales skills are just as...
eDetailing: Where are we in 2018?
Words by Dr Andrée Bates Detailing remains a core part of any pharmaceutical company’s sales approach and has become a large part of their promotional...
How can pharma harness the power of data to inform its scientific communications strategy?
Words by Simon Mason
Navigating the fast-changing healthcare data landscape is becoming increasingly challenging for pharma, owing to issues such as the rapid growth of...
Foreseeable future: MSD’s focus on emerging talent
Adelina Ismail
Role: Graduate Brand and Customer Manager, Vaccines & Women’s Health
Degree: BSc Marketing Management (Hons), Lancaster University
2-year graduate scheme: First year as a junior brand...
Gaining access: For products to commercially succeed it’s about what and who you know
Words by Andreas Knight
Many consider market access as a new component of commercial pharma, but in reality it has always been around in one...
Latest articles
Drug firms admit to colluding to keep up prices of antidepressants
Drug firms admit to colluding in order to keep up prices of antidepressants according to the Competition and Markets Authority (CMA). Two suppliers of the...
Licensing status of Avastin updated by MHRA
The licensing status of Avastin has been updated by the Medicines and Healthcare products Regulatory Agency (MHRA). The update concerns the licensing status of Avastin (bevacizumab)...
PM Society Digital Award Winners 2019
Thursday 19th September saw the tenth PM Society Digital Awards take place at The Brewery in London. Around 500 guests sat down to dinner...
Popular articles
Nurofen launches a 24 hour ibuprofen pain relief patch
Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen. Despite body pain being among the most commonly...
Licensing status of Avastin updated by MHRA
The licensing status of Avastin has been updated by the Medicines and Healthcare products Regulatory Agency (MHRA). The update concerns the licensing status of Avastin (bevacizumab)...
PM Society Digital Award Winners 2019
Thursday 19th September saw the tenth PM Society Digital Awards take place at The Brewery in London. Around 500 guests sat down to dinner...
Poor diabetes control costs the NHS £3bn in avoidable treatment
New research finds that poor diabetes control costs the NHS £3bn in potentially avoidable hospital treatment in England. The findings, being presented at this year’s...
Drug firms admit to colluding to keep up prices of antidepressants
Drug firms admit to colluding in order to keep up prices of antidepressants according to the Competition and Markets Authority (CMA). Two suppliers of the...